These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 187229)

  • 21. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of diphosphonates on the exchangeable and non-exchangeable calcium and phosphate of hydroxyapatite.
    Robertson WG; Morgan DB; Fleisch H; Francis MD
    Biochim Biophys Acta; 1971 Feb; 261(2):517-25. PubMed ID: 4335549
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth.
    Tew WP; Mahle C; Benavides J; Howard JE; Lehninger AL
    Biochemistry; 1980 Apr; 19(9):1983-8. PubMed ID: 7378389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Erosive polyarthropathy associated with mixed hydroxyapatite and calcium pyrophosphate crystal deposits].
    Bardin T; Dryll A; Durepaire H; Lemaire V; Lansaman J; Ryckewaert A
    Presse Med; 1984 Jun; 13(27):1700. PubMed ID: 6330722
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of hydroxyapatite formation in collagen gels by chondroitin sulphate.
    Hunter GK; Allen BL; Grynpas MD; Cheng PT
    Biochem J; 1985 Jun; 228(2):463-9. PubMed ID: 2990448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxyapatite and urate crystal induced cytokine release by macrophages.
    Alwan WH; Dieppe PA; Elson CJ; Bradfield JW
    Ann Rheum Dis; 1989 Jun; 48(6):476-82. PubMed ID: 2545171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characteristics of adsorption of pyrophosphate and citrate onto whewellite.
    Wagner M; Finlayson B
    Invest Urol; 1978 May; 15(6):456-8. PubMed ID: 206522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting the precipitation of calcium phosphate in vitro.
    Robertson WG
    Calcif Tissue Res; 1973 Mar; 11(4):311-22. PubMed ID: 4350499
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of ethane-1-hydroxy-1, 1-diphosphonate on bone turnover in adult dogs.
    Cabanela ME; Jowsey J
    Clin Orthop Relat Res; 1974 May; (100):364-9. PubMed ID: 4838421
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of disodium ethane-1-hydroxy-1, 1-diphosphonate on bone formation.
    King WR; Francis MD; Michael WR
    Clin Orthop Relat Res; 1971; 78():251-70. PubMed ID: 5110929
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dissolution kinetics of synthetic hydroxyapatite and human enamel crystals].
    Garnier P; Voegel JC; Frank RM
    J Biol Buccale; 1976 Dec; 4(4):323-30. PubMed ID: 12158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystals in joints.
    Lancet; 1980 May; 1(8176):1006-7. PubMed ID: 6103329
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure--activity relationship of inhibitors of hydroxyapatite formation.
    Williams G; Sallis JD
    Biochem J; 1979 Oct; 184(1):181-4. PubMed ID: 534518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission electron microscopic studies on articular calcium crystals and associated protein coatings.
    Schumacher HR; Cherian PV
    Scan Electron Microsc; 1984; (Pt 2):965-8. PubMed ID: 6091261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin (PG) E2 generation by cultured canine synovial fibroblasts exposed to microcrystals containing calcium.
    McCarty DJ; Cheung HS
    Ann Rheum Dis; 1985 May; 44(5):316-20. PubMed ID: 2988464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of pyrophosphate on hydroxyapatite with thioesters as condensing agents.
    Weber AL
    Biosystems; 1982; 15(3):183-9. PubMed ID: 6291672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of anti-calculus agents.
    Briner WW; Francis MD
    Calcif Tissue Res; 1973 Jan; 11(1):10-22. PubMed ID: 4696766
    [No Abstract]   [Full Text] [Related]  

  • 39. A model for human calcium pyrophosphate crystal deposition disease: crystallization kinetics in a gelatin matrix.
    Mandel NS; Mandel GS
    Scan Electron Microsc; 1984; (Pt 4):1779-92. PubMed ID: 6098005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.